Mechanistically, circFARP enhances leukemia inhibitory factor (LIF) expression by decoying miR-660-3p, and LIF secreted from CAFs induces gemcitabine resistance in pancreatic cancer cells by activating the LIF/STAT3 pathway. The gene discussed is STAT3; the disease is pancreatic neoplasm.